Sec. 11. As used in this chapter, "puberty blocking drugs" means: (1) gonadotropin releasing hormone analogues or other synthetic drugs used to stop luteinizing hormone and follicle stimulating hormone secretion; or (2) synthetic antiandrogen drugs used to block the androgen receptor; when used for the purpose of assisting an individual with a gender transition. As added by P.L.10-2023, SEC.1.